Lloyd J. Old

Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT).

Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT).

Life Science Pharmaceuticals, Inc. and its spin-out, Extended Delivery Pharmaceuticals (EDP), develop novel therapeutics to treat cancer, diabetes, and other serious illnesses. The private company is based in Darien, CT. Life Science Pharmaceuticals was founded in 2006 by James Fiore and Richard van Steen, and James Fiore has been the CEO since 2006. The company has a diverse portfolio of product candidates in pre-clinical and clinical development and fosters a close relationship with the academic community. LSP has licensing relationships with prestigious institutions such as the Ludwig Institute for Cancer Research (LICR), Memorial Sloan Kettering Cancer Center (MSKCC), Dana Farber Cancer Center (DFCI), and the Massachusetts Institute of Technology (MIT).